Pulmonx Corp (LUNG) - Comprehensive Stock Analysis & Investment Research
Company Overview & Business Profile
Pulmonx Corp (Stock Symbol: LUNG) is a leading company in the Industrial Applications and Services sector , specifically operating within the Surgical & Medical Instruments & Apparatus industry. The organization employs approximately 236 professionals worldwide . The company has established itself as an emerging investment opportunity with substantial growth potential.
Financial Performance & Key Metrics Analysis
Annual Revenue: $90 million generating a -104.0% net profit margin .
Market Capitalization: $70 million - Classified as a small-cap investment offering high growth potential.
Return on Equity (ROE): -26.1% - Below-average shareholder return efficiency, indicating areas for operational improvement.
Advanced AI Stock Prediction & Price Target Analysis
🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for Pulmonx Corp stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.
Market Position & Competitive Advantage Analysis
Pulmonx Corp strategically competes in the highly dynamic Surgical & Medical Instruments & Apparatus marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities . The company maintains a healthy 74.3% gross margin, indicating strong pricing power and operational efficiency.